Jeanne Tie

2010–2025 年に発表

72
論文数
18,373
被引用数
40
h 指数
66
i10 指数

被引用数

Jeanne Tie の年別被引用数1990 年: 被引用 3 件2007 年: 被引用 2 件2009 年: 被引用 1 件2010 年: 被引用 1 件2011 年: 被引用 5 件2012 年: 被引用 15 件2013 年: 被引用 22 件2014 年: 被引用 70 件2015 年: 被引用 146 件2016 年: 被引用 176 件2017 年: 被引用 231 件2018 年: 被引用 285 件2019 年: 被引用 907 件2020 年: 被引用 933 件2021 年: 被引用 1,021 件2022 年: 被引用 891 件2023 年: 被引用 873 件2024 年: 被引用 1,269 件2025 年: 被引用 849 件2026 年: 被引用 19 件1991〜2006 年は被引用が無いため表示していません2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,133 件、この内訳の 23.9%中国: 引用元論文 1,063 件、この内訳の 11.9%イタリア: 引用元論文 606 件、この内訳の 6.8%イギリス: 引用元論文 535 件、この内訳の 6%ドイツ: 引用元論文 430 件、この内訳の 4.8%フランス: 引用元論文 376 件、この内訳の 4.2%スペイン: 引用元論文 360 件、この内訳の 4%オーストラリア: 引用元論文 307 件、この内訳の 3.5%日本: 引用元論文 296 件、この内訳の 3.3%オランダ: 引用元論文 281 件、この内訳の 3.2%カナダ: 引用元論文 223 件、この内訳の 2.5%スイス: 引用元論文 161 件、この内訳の 1.8%
0%23.9%その他 24.1%

分野

  • Biochemistry, Genetics and Molecular Biology53.6%
  • Medicine41%
  • Engineering1.5%
  • Immunology and Microbiology1.4%
  • Chemistry0.7%
  • Computer Science0.5%
  • その他1.3%

トピック

  • Cancer Genomics and Diagnostics18.9%
  • Genetic factors in colorectal cancer5.5%
  • Cancer Cells and Metastasis5.2%
  • Colorectal Cancer Treatments and Studies4.5%
  • Lung Cancer Treatments and Mutations4.4%
  • Pancreatic and Hepatic Oncology Research3.8%
  • その他57.7%

共著者

全論文

検索で開く
  1. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz - Science Translational Medicine 2014 被引用: 5,110

  2. Detection and localization of surgically resectable cancers with a multi-analyte blood test

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jin Jen, Samir Hanash, Massimo Falconi, Peter J. Allen, Shibin Zhou, Chetan Bettegowda, Luis A. Díaz, Cristian Tomasetti, Kenneth W. Kinzler, Bert Vogelstein, Anne Marie Lennon, Nickolas Papadopoulos - Science 2018 被引用: 2,853

  3. Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 976

  4. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

    著者: , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2022 被引用: 664

  5. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2016 被引用: 1,469

  6. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 被引用: 692

  7. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2023 被引用: 178

  8. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Popoli, Michael Goggins, Ralph H. Hruban, Christopher L. Wolfgang, Alison P. Klein, Cristian Tomasetti, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Anne Marie Lennon - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 被引用: 572

  9. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

    著者: , , , , , , , , , , , , , , , , , - Annals of Oncology 2015 被引用: 644

  10. Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Volgestein, Peter Gibbs - Gut 2018 被引用: 392

  11. Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-overexpressing/amplified (HER2+) metastatic colorectal cancer (mCRC): Primary results from the multicenter, randomized, phase 2 DESTINY-CRC02 study.

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 77

  12. Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 181

  13. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2021 被引用: 177

  14. Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2024 被引用: 126

  15. Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2019 被引用: 213

  16. Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors

    著者: , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2020 被引用: 118

  17. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

    著者: , , , , , , , , , - Cancer 2011 被引用: 801

  18. Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers

    著者: , , , , , , , , , , , , , , - JCO Precision Oncology 2022 被引用: 95

  19. Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands

    著者: , , , , , , , , , , , , , , - Nature Biotechnology 2021 被引用: 91

  20. Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer

    著者: , , , , , , , , , , , , , , , - JAMA Oncology 2019 被引用: 240

  21. A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study

    著者: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2023 被引用: 52

  22. Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Cell Reports Medicine 2023 被引用: 40

  23. Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study.

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2024 被引用: 38

  24. Effect of Aspirin on Cancer Incidence and Mortality in Older Adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2020 被引用: 145